Keywords
Covid-19
epidemiology
treatment
prognosis
How to Cite
Abstract
Introduction :
Covid-19 is a contagious, systemic viral infection that affects the respiratory tract preferentially. SARS COV 2, the virus responsible for the disease, can also affect other organs Objective: To describe the epidemiological, clinical, biological, paraclinical and evolutionary aspects of COVID 19 at the Maradi Regional Hospital.
Material and methods :
This is a descriptive cross-sectional study based on the files of patients followed up for Covid-19 at the Maradi Regional Hospital Centre from March to October 2020.
Results :
A total of 11 patients were included (8 males and 3 females, mean age 51.77 years and sex-ratio 3.5). All patients had presented with fever and benefited from the PCR test and 6 patients had a notion of travel and/or contact. All the patients who died (36.36%) had comorbidities (hypertension, pelvic colon volvulus, asthma, etc.). The duration of hospitalization varied from 5 to 10 days.
Conclusion :
Covid-19 is a serious, deadly disease. There is no etiological treatment. Barrier measures and vaccination are the main weapons. The mortality recorded in our context was associated with the presence of comorbidities.
References
1. Wuhan Municipal Health Commission. Report of clustering pneumonia of unknown etiology in Wuhan City. 2019. www.who.int/emergencies/diseaseoutbreak-news/item/2020-DON229. Consulté le 18/02/2022.
2. Zhu N, Zhang D, Wang W et al. A Novel Coronavirus from patients with pneumonia in China, 2019. Engl J Med. 2020 ; 382 (8) : 727-73.
3. Ibrahim Mamadou AK, Harouna Amadou ML, Hama Aghali N, Nameywa B. Profil épidémiologique, clinique, paraclinique, thérapeutique et évolutif des patients infectés par le SARS-CoV-2 au Centre Hospitalier Régional de Dosso, République du Niger. Med afr noire. 2021 ; 68(12) : 701-9.
4. Kashongwe IM, Lepira FB, Situakibanza HN, Makulo JR, Sumaili EK, Kayembe JMN. Manifestations cliniques de l’infection à Coronavirus SARS-Cov-2 (COVID-19). Ann. Afr. Med., 2020 ;13 (3) : 3685-93.
5. Samaké D, Coulibaly M, Kéita M, Guindo O, Dembélé M, Traoré A, Kané A M, Traoré AS, Konaté MD, Traoré BK, Maiga A, Ousmane D, Traoré C, Traoré B, Dao S. Rev Mali Infect Microbiol 2021 ;16 : 47-51.
6. Savadogo M, Ouattara A, Dahani CK, Nikiéma O, Traoré S, Nagréongo B, Sawadogo N. Profil épidémiologique et clinique des cas suspects de COVID-19 reçus au CHU Yalgado Ouédraogo du Burkina Faso. Rev Mali Infect Microbiol 2021; 16 : 7-10.
7. Boushab MB, Fall-Malick FZ, Kelly M, Ould Ahmed Baba E, Ould Sidi Mohamed O, Ould Baba SW, Basco LK. Rev Mali Infect Microbiol 2021 ; 16 : 25-31.
8. Ngomas JF, Ifoudji Makao A, Nze Obiang PC, Nyangui DEM, Manga F, Bitegue L, Aspects Epidémiologiques et Facteurs de Mauvais Pronostic des Patients Atteints de COVID-19 Admis en Réanimation au Centre Hospitalier Universitaire de Libreville au Cours des Trois Premières Vagues de la Pandémie. Health Sci. Dis., 2022 ; 23 (6) : 1-7.
9. Byambasuren O, Cardona M, Bell K, Clark J, McLaws ML, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: systematic review and meta-analysis. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2020;5(4):223-34.
10. Donamou J, Bangoura A, Camara LM, Camara D, Traoré DA, Abékan RJM. Caractéristiques épidémiologiques et cliniques des patients COVID-19 admis en réanimation à l'hôpital Donka de Conakry, Guinée : étude descriptive des 140 premiers cas hospitalisés. Anesth Reanim. 2021; 7: 102–9.
11. Mwana-Yile H, Kampanga G, Mathe H, Diyoyo P, Ngalala A, Kilandamoko C, Kapongo R et al. Profile of COVID-19 positive patients admitted from March to June 2020 at the Sino-Congolese Friendship Hospital in N'djili from Kinshasa, Democratic Republic of Congo. Rev Mali Infect Microbiol 2021 ; 16 : 38-46
12. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study. Lancet. 2020;395(10223) :507-13.
13. Chih-Cheng Lai, Tzu-Ping Shih, Wen-Chien Ko, Hung-Jen Tang, and Po-Ren Hsueh. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3) : 105924.
14. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020 Aug;288(2):192-206.
15. Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med 2020;38(7): 1549.e3–1549.e7.
16. Mahieu R, Tillard L, Le Guillou-Guillemette H, Vinatier E, Jeannin P, Croué A, et al. No antibody response in acral cutaneous manifestations associated with COVID-19 ? J Eur Acad Dermatol Venereol. 2020 ; 34(10) : e546-e548.
17. Elloumi Kharrat H, Ghanem M, Bouali R, Elloumi H. Manifestations digestives de la COVID-19 : Prévalence et impact pronostique. LA TUNISIE MEDICALE 2020 ; 98 (08) : 643-50.
18. Collienne C, Castanares-Zapatero D, Apraxine M, Beauloye C, Capes A, Castelein T et al. Prise en charge aux soins intensifs des patients pour insuffisance respiratoire liée au COVID-19. Louvain Med. 2020 ; 139 (05-06) : 383-9.
19. Desvaux, É., & Faucher, J.-F. Covid-19 : aspects cliniques et principaux éléments de rise en charge. Revue Francophone Des Laboratoires, 2020(526), 40–7.
20. Mama Cisse I, Alassani A, Adjobimey M, Mikponhoue R, Hinsou AV, Attinsounon A et al. Infection au nouveau coronavirus chez un professionnel de la santé suite à un accès palustre. Rev Mali Infect Microbiol 2021 ;16 : 61-4.
21. Van Beckhoven D, Duysburgh E, Montourcy M, De Rouck M, Vilain A, Catteau L et al. Rapport thématique : points clés de la surveillance des patients hospitalisés atteints d’une infection covid19 confirmée, résultats du 15 mars au 14 juin 2020 inclus. Bruxelles, Belgique : Sciensano ; 2020. Numéro de dépôt légal : D/2020/14.440/65.
22. Harouna Amadou ML, Ibrahim Mamadou AK, Hama Aghali N, Nameywa B, Abdoulaye O, Amadou O et al. COVID 19, tuberculose et VIH : des associations possibles, y penser plus souvent ! Rev Mali Infect Microbiol 2021 ; 16 (3) : 6-10.
Metrics
Downloads
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 M Harouna Amadou, O Abdoulaye, O Amadou, A Ibrahim Mamadou, B Ahamadou, M Abdoulaye, M Mamane, C Maidakoualé, K Abdoul Aziz Amousso, M Doutchi